Read Again: Eye Implant Restores Sight for Blind Patients
- Here's a breakdown of the key information from the provided text, focusing on the PRIMA eye implant:
- * Not a cure: The PRIMA system doesn't restore normal vision.
- * Pixel Increase: The number of pixels in the chip is planned to increase dramatically, from 400 to 10,000.
Here’s a breakdown of the key information from the provided text, focusing on the PRIMA eye implant:
Current Status & Limitations:
* Not a cure: The PRIMA system doesn’t restore normal vision. Patients see in black and white, not colour.
* Surgical Risk: Implanting the chip is a complex surgery with inherent risks, including potential retinal atrophy (thinning).
* Training Required: Significant training is needed for patients to learn to interpret the visual information provided by the device.
* Quality of Life: It’s currently unclear if the improvements in vision considerably enhance patients’ quality of life.
* “Pre-Release iPhone”: Dr. Vavvas likens the current version to an early prototype, acknowledging limitations but recognizing potential.
Future Potential & Advancement:
* Pixel Increase: The number of pixels in the chip is planned to increase dramatically, from 400 to 10,000.
* 20/20 Vision Goal: With the increased pixel count and camera zoom, developers believe the system could theoretically achieve 20/20 visual resolution.
* Testing & Manufacturing: New chips have been tested in rats, and upgraded chips are being manufactured for future human trials.
* Timeline: New upgrades are expected within the next couple of years.
Key Players:
* Dr. Demetrios Vavvas: Retina specialist at Mass Eye and Ear, providing an expert opinion on the system.
* Daniel Palanker: stanford University professor who invented the PRIMA system.
* Science Corporation: California-based company developing the PRIMA system.